Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Osteogenesis imperfecta type XVIII (OI18) is characterized by congenital bowing of the long bones, wormian bones, blue sclerae, vertebral collapse, and multiple fractures in the first years of life ({1:Doyard et al., 2018}).
Features include always present findings: Femoral bowing, Joint hypermobility, Blue sclerae, and Recurrent fractures; and common findings: Wormian bones. 19 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 8 | Femoral bowing, Biconcave vertebral bodies, Joint hypermobility |
TENT5A function has not been fully characterized.
Osteogenesis imperfecta, type 18 is associated with mutations in the TENT5A gene on chromosome 6.
Genetic testing for TENT5A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for osteogenesis imperfecta, type 18 has been reported in the published literature.
Phenotype severity distribution: 4 always present features, 1 common feature.
No clinical trials have been registered for osteogenesis imperfecta, type 18.
47 publications have been identified in PubMed for osteogenesis imperfecta, type 18. Research spans Epidemiology / Natural History (30%), Case Report / Case Series (21%), and Clinical Trial Publication (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 14 | 30% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 1:48 AM UTC
Online Mendelian Inheritance in Man
Brain and nerves
1 |
Delayed speech and language development |
Age of onset: infancy, at birth.
Patient case studies
10 |
21% |
Clinical study results | 9 | 19% |
Laboratory research | 9 | 19% |
Research summaries | 3 | 6% |
Testing and diagnosis research | 2 | 4% |
Dossanov B (2026). [PMID: 42047125](https://pubmed.ncbi.nlm.nih.gov/42047125/). *Clin Ter*. [Clinical Trial Publication]
Drari S (2026). [PMID: 41938678](https://pubmed.ncbi.nlm.nih.gov/41938678/). *Cureus*. [Case Report / Case Series]
Nomura K (2026). [PMID: 42220822](https://pubmed.ncbi.nlm.nih.gov/42220822/). *Cureus*. [Case Report / Case Series]
Yamada C (2026). [PMID: 42036523](https://pubmed.ncbi.nlm.nih.gov/42036523/). *Calcif Tissue Int*. [Clinical Trial Publication]
Yamamoto A (2026). [PMID: 41920105](https://pubmed.ncbi.nlm.nih.gov/41920105/). *JACC Case Rep*. [Case Report / Case Series]
Patra S (2026). [PMID: 42147077](https://pubmed.ncbi.nlm.nih.gov/42147077/). *JCEM Case Rep*. [Case Report / Case Series]
Nguyen CV (2026). [PMID: 41568560](https://pubmed.ncbi.nlm.nih.gov/41568560/). *Journal of pediatric orthopedics*. [Clinical Trial Publication]
Tuurala H (2026). [PMID: 41618006](https://pubmed.ncbi.nlm.nih.gov/41618006/). *Calcified tissue international*. [Clinical Trial Publication]
Yamamoto K (2026). [PMID: 41660581](https://pubmed.ncbi.nlm.nih.gov/41660581/). *Bone reports*. [Case Report / Case Series]
Hayat S (2025). [PMID: 40219777](https://pubmed.ncbi.nlm.nih.gov/40219777/). *Journal of investigative medicine high impact case reports*. [Case Report / Case Series]